US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Oncocyte Corporation (OCX)
Oncocyte Corporation (OCX) ニュース

OCX

Oncocyte (OCX)

Oncocyte Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OCX

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/05	06 : 02	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:OCX	Oncocyte Corporation
2024/06/04	03 : 13	GlobeNewswire Inc.	Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study	NASDAQ:OCX	Oncocyte Corporation
2024/06/01	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2024/05/31	05 : 47	GlobeNewswire Inc.	Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine	NASDAQ:OCX	Oncocyte Corporation
2024/05/24	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2024/05/24	00 : 26	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:OCX	Oncocyte Corporation
2024/05/23	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:OCX	Oncocyte Corporation
2024/05/23	06 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2024/05/23	05 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2024/05/18	06 : 11	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:OCX	Oncocyte Corporation
2024/05/16	05 : 05	GlobeNewswire Inc.	Oncocyte Reports First Quarter 2024 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2024/05/13	21 : 00	GlobeNewswire Inc.	Oncocyte to Announce First Quarter 2024 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2024/05/11	06 : 31	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:OCX	Oncocyte Corporation
2024/05/07	22 : 19	GlobeNewswire Inc.	PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace	NASDAQ:OCX	Oncocyte Corporation
2024/04/12	19 : 00	GlobeNewswire Inc.	Oncocyte Reports Full Year 2023 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2024/04/12	10 : 46	GlobeNewswire Inc.	Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules	NASDAQ:OCX	Oncocyte Corporation
2024/04/12	06 : 30	GlobeNewswire Inc.	Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	NASDAQ:OCX	Oncocyte Corporation
2024/04/10	05 : 05	GlobeNewswire Inc.	Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2024/01/24	06 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2024/01/16	22 : 00	GlobeNewswire Inc.	Oncocyte to Present at the Sequire Investor Summit in Puerto Rico	NASDAQ:OCX	Oncocyte Corporation
2023/12/06	22 : 00	GlobeNewswire Inc.	Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays	NASDAQ:OCX	Oncocyte Corporation
2023/11/10	07 : 19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OCX	Oncocyte Corporation
2023/11/09	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2023/11/09	21 : 00	GlobeNewswire Inc.	Oncocyte Reports Third Quarter 2023 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2023/11/03	21 : 30	GlobeNewswire Inc.	Oncocyte to Announce Third Quarter 2023 Financial Results	NASDAQ:OCX	Oncocyte Corporation
2023/10/13	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCX	Oncocyte Corporation
2023/10/11	05 : 48	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:OCX	Oncocyte Corporation
2023/10/06	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2023/09/20	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation
2023/08/29	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCX	Oncocyte Corporation

Showing the most relevant articles for your search:NASDAQ:OCX

1 2 3 4 5 6 7 次へ >>

Deutsche Telekom (QX)

US Dollar vs Sterling

Gold vs US Dollar

Verizon Communications

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約